An atlas that catalogues gene activity and the levels of small molecules called metabolites in tumor samples offers a new way of identifying the deep mechanisms of cancer, according to researchers at Weill Cornell Medicine and Memorial Sloan...
Read more
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, extended survival for ...
Read more
Dear Friend of the Englander Institute for Precision Medicine, Welcome to our second quarterly external newsletter of 2023! Thank you for signing up on our website to receive this newsletter, we hope you enjoy learning more about the important...
Read more
Tumor cells are known to be fickle sleeper agents, often lying dormant in distant tissues for years before reactivating and forming metastasis. Numerous factors have been studied to understand why the activation occurs, from cells and molecules...
Read more
“This work is my heart and soul,” says Dr. Lisa Newman. Taking care of breast cancer patients is her passion and one that led her and her colleagues to travel nearly 5,000 miles to Africa several times a year to see patients and help...
Read more
Dear Friend of the Englander Institute for Precision Medicine, Welcome to our second quarterly external newsletter of 2023! Thank you for signing up on our website to receive this newsletter, we hope you enjoy learning more...
Read more
Dear Members of the Englander Institute, Thank you all so much for another very successful and productive month! I hope you enjoy reading about June’s accomplishments, that include new awards, news coverage of our work, abstracts presented...
Read more
Dear Members of the Englander Institute,Thank you all so much for another very successful and productive month!I hope you enjoy reading about May’s accomplishments, that include staff promotions, elections to professional committees, news...
Read more
Biomedical Engineering Symposium Showcases Research and Facilitates Collaborations A two-day intercampus event, the “Biomedical Engineering Symposium: Tools to Transform Discovery & Care,” recently brought together dozens of specialists in...
Read more
Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to Weill Cornell...
Read more
The Bridge2AI-Voice Consortium, a program based on the NIH-funded study called Voice as a Biomarker of Health that is co-led by experts from Weill Cornell Medicine’s Englander Institute for Precision Medicine (EIPM) and the USF Health...
Read more
Dear Friend of the Englander Institute for Precision Medicine,Welcome to our first quarterly external newsletter of 2023!Thank you for signing up on our website to receive this newsletter, we hope you enjoy learning more about the important...
Read more